US 8163732
Tricyclic heteroaryl compounds useful as inhibitors of Janus kinase
granted A61PA61P1/04A61P11/00
Quick answer
US patent 8163732 (Tricyclic heteroaryl compounds useful as inhibitors of Janus kinase) held by Vertex Pharmaceuticals Incorporated expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61P, A61P1/04, A61P11/00, A61P11/06, A61P11/08